<DOC>
	<DOCNO>NCT00217516</DOCNO>
	<brief_summary>RATIONALE : The use nutritional supplement , selenium , may stop prostate cancer grow . Internal radiation , brachytherapy , use radioactive material place directly near tumor kill tumor cell . Giving selenium brachytherapy may effective treatment prostate cancer . PURPOSE : This randomized phase I trial study selenium see well work compare placebo treat patient undergo brachytherapy stage I stage II prostate cancer .</brief_summary>
	<brief_title>Selenium Treating Patients Who Are Undergoing Brachytherapy Stage I Stage II Prostate Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Compare effect selenium vs placebo tissue biomarkers prostate cancer susceptibility , use tissue sample biopsy treatment , patient undergo brachytherapy stage I II prostate cancer . Secondary - Determine effect selenium antioxidant enzyme activity patient . - Determine , preliminarily , whether threshold effect among patient low baseline level selenium treat drug . OUTLINE : Patients randomize 1 2 treatment arm . - Arm I : Patients receive oral selenium 3-6 week . Patients undergo brachytherapy . - Arm II : Patients receive oral placebo 3-6 week . Patients undergo brachytherapy . After completion study treatment , patient follow 1 6 month .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Selenium</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm adenocarcinoma prostate Must undergone â‰¥ sextant biopsy Clinical stage T1aT2a disease Gleason score &lt; 8 Prostatespecific antigen &lt; 20 ng/mL PATIENT CHARACTERISTICS : Age Not specify Performance status Not specify Life expectancy More 5 year Hematopoietic Not specify Hepatic Not specify Renal Not specify Other No prior malignancy except nonmelanoma skin cancer PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy No prior hormonal therapy Radiotherapy No prior radiotherapy Surgery Not specify Other More 30 day since prior concurrent participation another clinical trial involve medical , surgical , nutritional , lifestyle intervention ( e.g. , dietary modification exercise ) No selenium dose &gt; 50 mcg/day dietary supplement , include multivitamin supplement</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>adenocarcinoma prostate</keyword>
	<keyword>stage I prostate cancer</keyword>
	<keyword>stage II prostate cancer</keyword>
</DOC>